JOHNSON P. S. Pfizer Global Research &Development

Compounds of formula (I), or pharmaceutically acceptable derivatives thereof,wherein R represents H, C1-6 alkyl, SO2R1, SO2NR1R2,or COR1; R1 and R2 independently represent C1-6alkyl; and Ring A represents a phenyl ring or a pyridinyl ring; …

Compounds of formula (I), or pharmaceutically acceptable derivatives thereof,wherein R represents H, C1-6 alkyl, SO2R1, SO2NR1R2,or COR1; R1 and R2 independently represent C1-6alkyl; and Ring A represents a phenyl ring or a pyridinyl ring; …

Compounds of formula (I), or pharmaceutically acceptable derivatives thereof,wherein R represents H, C1-6 alkyl, SO2R1, SO2NR1R2,or COR1; R1 and R2 independently represent C1-6alkyl; and Ring A represents a phenyl ring or a pyridinyl ring; …

Compounds of formula (I), or pharmaceutically acceptable derivatives thereof,wherein R represents H, C1-6 alkyl, SO2R1, SO2NR1R2,or COR1; R1 and R2 independently represent C1-6alkyl; and Ring A represents a phenyl ring or a pyridinyl ring; …

Compounds of formula (I), or pharmaceutically acceptable derivatives thereof,wherein R represents H, C1-6 alkyl, SO2R1, SO2NR1R2,or COR1; R1 and R2 independently represent C1-6alkyl; and Ring A represents a phenyl ring or a pyridinyl ring; …

Compounds of formula (I), or pharmaceutically acceptable derivatives thereof,wherein R represents H, C1-6 alkyl, SO2R1, SO2NR1R2,or COR1; R1 and R2 independently represent C1-6alkyl; and Ring A represents a phenyl ring or a pyridinyl ring; …

Compounds of formula (I), or pharmaceutically acceptable derivatives thereof,wherein R represents H, C1-6 alkyl, SO2R1, SO2NR1R2,or COR1; R1 and R2 independently represent C1-6alkyl; and Ring A represents a phenyl ring or a pyridinyl ring; …

Compounds of formula (I), or pharmaceutically acceptable derivatives thereof,wherein R represents H, C1-6 alkyl, SO2R1, SO2NR1R2,or COR1; R1 and R2 independently represent C1-6alkyl; and Ring A represents a phenyl ring or a pyridinyl ring; …

Compounds of formula (I), or pharmaceutically acceptable derivatives thereof,wherein R represents H, C1-6 alkyl, SO2R1, SO2NR1R2,or COR1; R1 and R2 independently represent C1-6alkyl; and Ring A represents a phenyl ring or a pyridinyl ring; …

Compounds of formula (I), or pharmaceutically acceptable derivatives thereof,wherein R represents H, C1-6 alkyl, SO2R1, SO2NR1R2,or COR1; R1 and R2 independently represent C1-6alkyl; and Ring A represents a phenyl ring or a pyridinyl ring; …

Compounds of formula (I), or pharmaceutically acceptable derivatives thereof,wherein R represents H, C1-6 alkyl, SO2R1, SO2NR1R2,or COR1; R1 and R2 independently represent C1-6alkyl; and Ring A represents a phenyl ring or a pyridinyl ring; …

Compounds of formula (I), or pharmaceutically acceptable derivatives thereof,wherein R represents H, C1-6 alkyl, SO2R1, SO2NR1R2,or COR1; R1 and R2 independently represent C1-6alkyl; and Ring A represents a phenyl ring or a pyridinyl ring; …

Compounds of formula (I), or pharmaceutically acceptable derivatives thereof,wherein R represents H, C1-6 alkyl, SO2R1, SO2NR1R2,or COR1; R1 and R2 independently represent C1-6alkyl; and Ring A represents a phenyl ring or a pyridinyl ring; …

Compounds of formula (I), or pharmaceutically acceptable derivatives thereof,wherein R represents H, C1-6 alkyl, SO2R1, SO2NR1R2,or COR1; R1 and R2 independently represent C1-6alkyl; and Ring A represents a phenyl ring or a pyridinyl ring; …

Compounds of formula (I), or pharmaceutically acceptable derivatives thereof,wherein R represents H, C1-6 alkyl, SO2R1, SO2NR1R2,or COR1; R1 and R2 independently represent C1-6alkyl; and Ring A represents a phenyl ring or a pyridinyl ring; …

Compounds of formula (I), or pharmaceutically acceptable derivatives thereof,wherein R represents H, C1-6 alkyl, SO2R1, SO2NR1R2,or COR1; R1 and R2 independently represent C1-6alkyl; and Ring A represents a phenyl ring or a pyridinyl ring; …

Compounds of formula (I), or pharmaceutically acceptable derivatives thereof,wherein R represents H, C1-6 alkyl, SO2R1, SO2NR1R2,or COR1; R1 and R2 independently represent C1-6alkyl; and Ring A represents a phenyl ring or a pyridinyl ring; …

Compounds of formula (I), or pharmaceutically acceptable derivatives thereof,wherein R represents H, C1-6 alkyl, SO2R1, SO2NR1R2,or COR1; R1 and R2 independently represent C1-6alkyl; and Ring A represents a phenyl ring or a pyridinyl ring; …

Compounds of formula (I), or pharmaceutically acceptable derivatives thereof,wherein R represents H, C1-6 alkyl, SO2R1, SO2NR1R2,or COR1; R1 and R2 independently represent C1-6alkyl; and Ring A represents a phenyl ring or a pyridinyl ring; …

Compounds of formula (I), or pharmaceutically acceptable derivatives thereof,wherein R represents H, C1-6 alkyl, SO2R1, SO2NR1R2,or COR1; R1 and R2 independently represent C1-6alkyl; and Ring A represents a phenyl ring or a pyridinyl ring; …

Compounds of formula (I), or pharmaceutically acceptable derivatives thereof,wherein R represents H, C1-6 alkyl, SO2R1, SO2NR1R2,or COR1; R1 and R2 independently represent C1-6alkyl; and Ring A represents a phenyl ring or a pyridinyl ring; …

Compounds of formula (I), or pharmaceutically acceptable derivatives thereof,wherein R represents H, C1-6 alkyl, SO2R1, SO2NR1R2,or COR1; R1 and R2 independently represent C1-6alkyl; and Ring A represents a phenyl ring or a pyridinyl ring; …

Compounds of formula (I), or pharmaceutically acceptable derivatives thereof,wherein R represents H, C1-6 alkyl, SO2R1, SO2NR1R2,or COR1; R1 and R2 independently represent C1-6alkyl; and Ring A represents a phenyl ring or a pyridinyl ring; …

Compounds of formula (I), or pharmaceutically acceptable derivatives thereof,wherein R represents H, C1-6 alkyl, SO2R1, SO2NR1R2,or COR1; R1 and R2 independently represent C1-6alkyl; and Ring A represents a phenyl ring or a pyridinyl ring; …

Compounds of formula (I), or pharmaceutically acceptable derivatives thereof,wherein R represents H, C1-6 alkyl, SO2R1, SO2NR1R2,or COR1; R1 and R2 independently represent C1-6alkyl; and Ring A represents a phenyl ring or a pyridinyl ring; …